<DOC>
<DOCNO>EP-0627407</DOCNO> 
<TEXT>
<INVENTION-TITLE>
(7S)-7-(2(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31185	A61K3119	A61P100	A61P104	A61P300	A61P304	A61P2500	A61P2524	A61P2526	A61P2700	A61P2702	C07C21700	C07C21754	C07C21762	C07C21774	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07C	C07C	C07C	C07C	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P1	A61P1	A61P3	A61P3	A61P25	A61P25	A61P25	A61P27	A61P27	C07C217	C07C217	C07C217	C07C217	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates, as new compound, to {(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino]-5,6,7,8-tetrahyd ro-2-naphthyloxy}acetic acid of formula (I) 
<
IMAGE
>
 and to its pharmaceutically acceptable salts, with ss3-adrenergic agonist activity, and to the pharmaceutical compositions containing it. Application: treatment and/or prophylaxis of pathological conditions which can be improved using an agonist activity by mediation by receptors of the ss3-adrenergic type.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
MIDY SPA
</APPLICANT-NAME>
<APPLICANT-NAME>
MIDY S.P.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BARONI MARCO
</INVENTOR-NAME>
<INVENTOR-NAME>
CECCHI ROBERTO
</INVENTOR-NAME>
<INVENTOR-NAME>
CROCI TIZIANO
</INVENTOR-NAME>
<INVENTOR-NAME>
BARONI, MARCO
</INVENTOR-NAME>
<INVENTOR-NAME>
CECCHI, ROBERTO
</INVENTOR-NAME>
<INVENTOR-NAME>
CROCI, TIZIANO
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
